Interferon-beta antibodies: implications for the treatment of MS

Lancet Neurol. 2003 Sep;2(9):528. doi: 10.1016/s1474-4422(03)00499-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies / immunology
  • Humans
  • Interferon-beta / immunology*
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / drug therapy*

Substances

  • Antibodies
  • Interferon-beta